A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation
NCT05514119
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class
Stopped
Low Enrollment
Conditions
Liver Transplant
Interventions
DRUG:
Fenofibrate
Sponsor
Mayo Clinic